Inversago Pharma lands $7 mln Series A
Montreal-based Inversago Pharma Inc, a biotech firm, has secured $7 million in Series A financing. Genesys Capital and Amorchem led the round with participation from other investors that included JDRF T1D Fund, Accel-Rx, Anges Québec Capital, Anges Québec and Tarnagulla Ventures.
25 July 2018•1 min read
